{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:07:08Z","timestamp":1787612828374,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T00:00:00Z","timestamp":1111017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T00:00:00Z","timestamp":1111017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1038\/sj.ijir.3901313","type":"journal-article","created":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T10:06:40Z","timestamp":1111054000000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1"],"prefix":"10.1038","volume":"17","author":[{"given":"R","family":"Seyam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Al","family":"Akhras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Rashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,17]]},"reference":[{"key":"BF3901313_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0090-4295(99)00612-3","volume":"55","author":"R Shabsigh","year":"2000","unstructured":"Shabsigh R et al. Intracavernous alprostadil alfadex (EDEX\/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000; 55: 477\u2013480.","journal-title":"Urology"},{"key":"BF3901313_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0022-5347(05)67140-6","volume":"164","author":"DG Hatzichristou","year":"2000","unstructured":"Hatzichristou DG et al. Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 2000; 164: 1197\u20131200.","journal-title":"J Urol"},{"key":"BF3901313_CR3","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/S0022-5347(01)65419-3","volume":"156","author":"DK Montague","year":"1996","unstructured":"Montague DK et al. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol 1996; 156: 2007\u20132011.","journal-title":"J Urol"},{"key":"BF3901313_CR4","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/S0022-5347(17)35906-2","volume":"150","author":"B von Heyden","year":"1993","unstructured":"von Heyden B et al. A prostaglandin E1 dose\u2013response study in man. J Urol 1993; 150: 1825\u20131828.","journal-title":"J Urol"},{"key":"BF3901313_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijir.3900260","volume":"9","author":"M Ismail","year":"1997","unstructured":"Ismail M, Abbott L, Hirsch IH . Experience with intracavernous PGE-1 in the treatment of erectile dysfunction: dose considerations and efficacy. Int J Impot Res 1997; 9: 39\u201342.","journal-title":"Int J Impot Res"},{"key":"BF3901313_CR6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0022-5347(17)38167-3","volume":"146","author":"AH Bennett","year":"1991","unstructured":"Bennett AH, Carpenter AJ, Barada JH . An improved vasoactive drug combination for a pharmacological erection program. J Urol 1991; 146: 1564\u20131565.","journal-title":"J Urol"},{"key":"BF3901313_CR7","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0022-5347(17)35905-0","volume":"150","author":"FE Govier","year":"1993","unstructured":"Govier FE et al. Experience with triple-drug therapy in a pharmacological erection program. J Urol 1993; 150: 1822\u20131824.","journal-title":"J Urol"},{"key":"BF3901313_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/0090-4295(94)90147-3","volume":"43","author":"GA Marshall","year":"1994","unstructured":"Marshall GA, Breza J, Lue TF . Improved hemodynamic response after long-term intracavernous injection for impotence. Urology 1994; 43: 844\u2013848.","journal-title":"Urology"},{"key":"BF3901313_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0022-5347(01)66964-7","volume":"154","author":"O Shenfeld","year":"1995","unstructured":"Shenfeld O et al. Papaverine\u2013phentolamine and prostaglandin E1 versus papaverine\u2013phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. J Urol 1995; 154: 1017\u20131019.","journal-title":"J Urol"},{"key":"BF3901313_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0022-5347(05)68269-9","volume":"162","author":"JP Mulhall","year":"1999","unstructured":"Mulhall JP et al. The causes of patient dropout from penile self-injection therapy for impotence. J Urol 1999; 162: 1291\u20131294.","journal-title":"J Urol"},{"issue":"Suppl 1","key":"BF3901313_CR11","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1038\/sj.ijir.3900808","volume":"14","author":"F Montorsi","year":"2002","unstructured":"Montorsi F et al. Current status of local penile therapy. Int J Impot Res 2002; 14(Suppl 1): S70\u2013S81.","journal-title":"Int J Impot Res"},{"key":"BF3901313_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.ijir.3900812","volume":"14","author":"S Israilov","year":"2002","unstructured":"Israilov S et al. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. Int J Impot Res 2002; 14: 38\u201343.","journal-title":"Int J Impot Res"},{"key":"BF3901313_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319\u2013326.","journal-title":"Int J Impot Res"},{"key":"BF3901313_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.ijir.3900377","volume":"11","author":"P Kunelius","year":"1999","unstructured":"Kunelius P, Lukkarinen O . Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction. Int J Impot Res 1999; 11: 21\u201324.","journal-title":"Int J Impot Res"},{"key":"BF3901313_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0022-5347(05)64690-3","volume":"168","author":"D Hatzichristou","year":"2002","unstructured":"Hatzichristou D et al. Diagnostic steps in the evaluation of patients with erectile dysfunction. J Urol 2002; 168: 615\u2013620.","journal-title":"J Urol"},{"key":"BF3901313_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0022-5347(01)66344-4","volume":"155","author":"A Bechara","year":"1996","unstructured":"Bechara A et al. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. J Urol 1996; 155: 913\u2013914.","journal-title":"J Urol"},{"key":"BF3901313_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.ijir.3900543","volume":"12","author":"I Goldstein","year":"2000","unstructured":"Goldstein I et al. Axial penile rigidity as primary efficacy outcome during multi-institutional in-office dose titration clinical trials with alprostadil alfadex in patients with erectile dysfunction. Alprostadil Alfadex Study Group. Int J Impot Res 2000; 12: 205\u2013211.","journal-title":"Int J Impot Res"},{"key":"BF3901313_CR18","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/S0022-5347(01)66774-0","volume":"154","author":"D Vanderschueren","year":"1995","unstructured":"Vanderschueren D et al. A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group. J Urol 1995; 154: 1744\u20131747.","journal-title":"J Urol"},{"key":"BF3901313_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2214\/ajr.153.6.1141","volume":"153","author":"JP Quam","year":"1989","unstructured":"Quam JP et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. Am J Roentgenol 1989; 153: 1141\u20131147.","journal-title":"Am J Roentgenol"},{"key":"BF3901313_CR20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0022-5347(01)66315-8","volume":"155","author":"H Porst","year":"1996","unstructured":"Porst H . The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996; 155: 802\u2013815.","journal-title":"J Urol"},{"key":"BF3901313_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.ijir.3900307","volume":"10","author":"A Casabe","year":"1998","unstructured":"Casabe A et al. Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction. Int J Impot Res 1998; 10: 5\u20139.","journal-title":"Int J Impot Res"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3901313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3901313","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3901313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:10:22Z","timestamp":1648671022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3901313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,17]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7,1]]}},"alternative-id":["BF3901313"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijir.3901313","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,17]]},"assertion":[{"value":"1 October 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}